A recent paid advertisement for Bio-Rad Laboratories' TransFectin lipid reagent mentioned the benefits of using the product in conjunction with DNA-directed RNAi experiments. Although the announcement is not unusual in and of itself, the term ddRNAi has been used solely by Benitec to describe its RNAi technology.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.